UltraMIST® Therapy System
Chronic, Non-Healing Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers)
Key Facts
About Sanuwave
Sanuwave is a commercial-stage medical device company focused on shifting the standard of care for chronic wounds through its proprietary non-contact, low-frequency ultrasound (NCLFU) technology. Its flagship UltraMIST® System, cleared by the FDA, is central to the company's 'Energy First™' protocol, aiming to jumpstart stalled healing, reduce pain, and improve patient outcomes. The company's strategy hinges on driving commercial adoption in the massive advanced wound care market while generating robust clinical and economic data to secure broader reimbursement and provider acceptance.
View full company profileAbout Sanuwave
Sanuwave is a commercial-stage medical device company focused on shifting the standard of care for chronic wounds through its proprietary non-contact, low-frequency ultrasound (NCLFU) technology. Its flagship UltraMIST® System, cleared by the FDA, is central to the company's 'Energy First™' protocol, aiming to jumpstart stalled healing, reduce pain, and improve patient outcomes. The company's strategy hinges on driving commercial adoption in the massive advanced wound care market while generating robust clinical and economic data to secure broader reimbursement and provider acceptance.
View full company profile